Introducing Our Cutting-Edge, Fully Automated 3D Histology Platform
IMAI Medtech presents an innovative 3D histology platform designed to revolutionize cancer diagnostics. Our technology significantly reduces false negatives, fully automates the diagnostic process, enables rapid staining and ensures easy operation. It offers unparalleled tissue visualization and can be customized to meet specific clinical and research needs. By improving early diagnosis and accuracy, we aim to improve therapeutic outcomes and patient care.
B
Full process automation. Empowering Precision & Enhancing Speed with Automation
IMAI introduces the future of histopathology with our fully automated 3D histology platform. In synergy with advanced light-sheet microscopy technologies (www.mesoSPIM.org), this state-of-the-art device optimizes the entire histology process, from tissue processing to analysis, ensuring accuracy, efficiency, and reproducibility. Designed to minimize human intervention, our technology promises to revolutionize cancer diagnostics by providing faster and more accurate results. Stay tuned for an exclusive video of our automation process, narrated by co-founder Sascha, illustrating the seamless operation of our innovative platform.
C
Rapid staining: Speeds up the staining process, reducing waiting time
Leveraging cutting-edge electrical and mechanical engineering together with customized protocols, our technology significantly optimizes 3D staining of dense tissue samples. This innovative approach dramatically reduces staining time, achieving results in up to 24 hours. Try a taste of our rapid staining process and understand how IMAI is setting new standards in histological analysis.
D
User friendly. Simplifies operations, making protocols accessible to all laboratory personnel.
The IMAI platform transforms complex histology processes into simple and streamlined protocols. This feature is designed to democratize access to advanced diagnostics and research settings, making it easy for all laboratory personnel to use the system. By simplifying operations, we ensure that state-of-the-art histology is within the reach of all research and clinical laboratories, facilitating wider adoption and promoting innovation in cancer diagnostics.
E
Tissue visualization: Provides an enhanced view of tissue structures for more informed decision making
IMAI, in synergy with advanced light-sheet microscopy such as the mesoSPIM (www.mesoSPIM.org), reveals detailed views of biological samples. Our showcases include:
Metastatic lymph node detail: The first video illustrates a metastatic lymph node in its entirety, with cytokeratin-positive cells highlighted in green, offering a vivid representation of tumor cell distribution.
Insight into the hippocampal region of the brain: The second and third videos presents the hippocampal region of the human brain, emphasizing nuclei and microglial cells to shed light on its intricate cellular architecture.
These demonstrations highlight IMAI's ability to illuminate complex tissue structures crucial to understanding pathology and normal biological processes. Light-sheet imaging is performed using the mesoSPIM V6 microscope at the Center for Microscopy and Image Analysis (ZMB), University of Zurich. More information about this open-source project at www.mesospim.org.
F
Custom solutions: Offers tailored adaptations to meet the unique needs of research and clinical settings.
The IMAI platform transforms complex histology processes into simple and streamlined protocols. This feature is designed to democratize access to advanced diagnostics and research settings, making it easy for all laboratory personnel to use the system. By simplifying operations, we ensure that state-of-the-art histology is within the reach of all research and clinical laboratories, facilitating wider adoption and promoting innovation in cancer diagnostics.
A
False negative reduction. Dramatically reduces the rate of missed cancer diagnoses.
IMAI's innovative technology significantly reduces false negatives in cancer diagnostics, boasting a 98 percent reduction rate. Enabling the detection of over 400 times more cells within the entire tissue sample, IMAI's advanced 3D histology platform ensures comprehensive analysis that greatly improves the accuracy of cancer diagnoses. This feature represents a fundamental advance in the early detection and treatment of cancer, setting a new benchmark for diagnostic accuracy in healthcare.
